|
SEC24C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.721360E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.429400E-01 |
| Normal-vs-Stage2 |
9.270400E-01 |
| Normal-vs-Stage3 |
1.363670E-02 |
| Normal-vs-Stage4 |
4.509800E-02 |
| Stage1-vs-Stage2 |
6.469200E-01 |
| Stage1-vs-Stage3 |
1.537980E-02 |
| Stage1-vs-Stage4 |
9.455700E-02 |
| Stage2-vs-Stage3 |
7.416200E-02 |
| Stage2-vs-Stage4 |
1.253240E-01 |
| Stage3-vs-Stage4 |
8.987000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.469900E-02 |
| Normal-vs-AfricanAmerican |
9.755600E-01 |
| Normal-vs-Asian |
8.359600E-01 |
| Caucasian-vs-AfricanAmerican |
2.980400E-01 |
| Caucasian-vs-Asian |
1.264760E-01 |
| AfricanAmerican-vs-Asian |
9.031200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.004000E-02 |
| Normal-vs-Female |
2.994400E-01 |
| Male-vs-Female |
2.654200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.187200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.671900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.265010E-01 |
| Normal-vs-Age(81-100Yrs) |
2.447400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.846200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.076420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.583960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.670000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.367600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.932600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.442600E-03 |
| Classical-VS-Follicular |
2.613400E-01 |
| Classical-VS-Other |
5.939900E-02 |
| Classical-VS-Normal |
2.405400E-01 |
| Tall-VS-Follicular |
6.164800E-04 |
| Tall-VS-Other |
7.045800E-01 |
| Tall-VS-Normal |
1.217790E-04 |
| Follicular-VS-Other |
1.276560E-01 |
| Follicular-VS-Normal |
7.879600E-01 |
| Other-VS-Normal |
9.501100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.571200E-01 |
| Normal-vs-N1 |
3.682400E-03 |
| N0-vs-N1 |
1.065780E-02 |
|
|
